Articles

3 Nasdaq Stocks Facing Regulatory Hot Water in 2023

Investors should certainly avoid these three Nasdaq stocks in trouble, and shorting them could turn out to be very profitable. More

Why Is Dermata Therapeutics (DRMA) Stock Up 23% Today?

Dermata Therapeutics (DRMA) stock is taking off on Friday despite a lack of news from the clinical-stage biotechnology company. More

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday! More

Even at Under a Nickel, XELA Stock Isn’t Worth a Penny

Taking all factors into account, it's clear why I believe XELA stock today isn't worth even a penny. More

4 Bank Stocks STILL Paying Secure Dividends

The banking crisis sparked by the failure of SVB has resulted in some very safe banks offering some very fat dividends. More

7 Biotech Stocks Sitting in the Sweet Spot

Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. More

ALLY Stock: Ignore the Buffett Rumors, Stay Away

Following the bank sector sell-off, there may be some worthwhile bargains out there, but ALLY stock isn't one of them. Tune out the takeover talk, and steer clear. More